For instance, FLT3ITD TET2 (1, 5), FLT3ITDDNMT3A (2), DNMT3A TET2 (6, 7), or FLT3ITD NPM1 (8) mutations frequently coexist in normal CN patients with AML (9–11). The gene discussed is TET2; the disease is acute myeloid leukemia.